Approaches to Reduce Therapeutic Inertia in Diabetes Management
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
Type 2 Diabetes Information Center
Bydureon BCise Approved for Adolescents With Type 2 Diabetes
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes
Researchers studied the effectiveness of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin without prandial insulin in primary care practices.
Bariatric Gastric Bypass Surgery Alters Gut Microbiome in Adults With T2D and Mild Obesity
Researchers assessed how gut microbiota changes are associated with anthropometric, metabolic, and inflammatory profiles following metabolic surgery in adults with type 2 diabetes and mild obesity.
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
ADA: Peds Hospitalization Rates for New-Onset T2D Up During Pandemic
Hospitalization rate for new-onset diabetes in children up from 0.27% in 2019 to 0.62% in 2020.
NP-Led Diabetes Education Reduces Sedentary Behaviors
NP-led educational intervention decreases sedentary behavior and blood glucose levels in patients with type 2 diabetes.
Reducing Social Isolation Is Key to Successful Aging
Prior to the COVID-19 pandemic, that more than 60% of US adults were lonely; these numbers only increased during the pandemic. Clinicians should focus more time on the psychological and social factors of aging to improve the quality of life of the elderly.
Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
Burden of Depressive Symptoms High in T1D, T2D in Developing Countries
The researchers evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from an international study to glean information about people in developing countries.
Does Hybrid Telerehabilitation Benefit Patients With HF and Comorbid T2D?
The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.
Diet Can Reduce Blood Pressure in Type 2 Diabetes
Sixty-nine of 78 participants with type 2 diabetes on treatment for hypertension stopped all or some antihypertensive and diuretic medications.
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
Icodec results in greater increase in time-in-range versus once-daily insulin glargine U100 in two phase 2 randomized, open-label trials
Unexpected Cause of Type 2 Diabetes and Debilitating Fatigue: A Case Study
Man with a 10-year history of type 2 diabetes presents with new symptoms of proximal muscle weakness and profound fatigue. Could he have a secondary cause of diabetes?
Diabetes Cost-of-Care Conversations Needed in Primary Care
Diabetes is one of the most expensive chronic diseases, yet few patients discuss cost-of-treatment with their primary care physicians.
Genome-Wide Significant Genes Identified for Youth-Onset Type 2 Diabetes
The ProDiGY consortium examined the effect of known genetic variants associated with T2D on adults with youth-onset diabetes.
Long-Term BP Variability Linked to Cardiovascular Mortality in T2D
Greater variability in systolic blood pressure and diastolic blood pressure was associated with increased CVD mortality risk in T2D.
Guideline-Noncompliant Opioids Prescribed for Many With Diabetic Peripheral Neuropathy
Opioids were prescribed to nearly 43% of patients newly diagnosed with diabetic peripheral neuropathy who were started on pain medications.
Spinal Cord Stimulation May Provide Relief in Painful Diabetic Neuropathy
At follow-up, 65.9% of the treatment group and 8.5% of the control cohort exhibited improvements in painful diabetic neuropathy.
Gender, Race Affects Access to SGLT2-Inhibitor Therapy for Type 2 Diabetes
Black race, Asian race, and female gender were associated with lower rates of SGLT2 inhibitor use in patients with type 2 diabetes.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...